PT-141

PT-141 works directly through the nervous system to increase arousal, desire, and satisfaction with sex. Although most of the research has been targeted to women with female sexual dysfunction it has been found to be an  effective medication in treating sexual dysfunction in both men (erectile dysfunction or impotence) and women (sexual arousal disorder).

Unlike Viagra and other related medications, it does not act upon the vascular system, but directly increases sexual desire via the nervous system. It is estimated that 43% of women (30 million is the US) suffer from sexual dysfunction and 30 million men suffer from ED, with incidence increasing 2-3 fold between ages 40-70. Bremelanotide currently has no contraindications and is 80% effective in men don’t respond to Viagra or Cialis. For women, it causes a 50% increase in sexually satisfying experiences.